Raymond James Downgrades Adverum Biotechnologies (ADVM) to Market Perform

November 2, 2018 5:10 AM

Raymond James analyst Reni Benjamin downgraded Adverum Biotechnologies (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found